PROCTER & GAMBLE HEALTH | BH.IMMUN&BIO | PROCTER & GAMBLE HEALTH/ BH.IMMUN&BIO |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | -8.0 | - | View Chart |
P/BV | x | 10.6 | 1.6 | 670.4% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH BH.IMMUN&BIO |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
BH.IMMUN&BIO Mar-23 |
PROCTER & GAMBLE HEALTH/ BH.IMMUN&BIO |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 52 | 10,358.3% | |
Low | Rs | 3,883 | 21 | 18,941.5% | |
Sales per share (Unadj.) | Rs | 740.7 | 10.3 | 7,170.1% | |
Earnings per share (Unadj.) | Rs | 138.2 | -3.9 | -3,587.3% | |
Cash flow per share (Unadj.) | Rs | 155.2 | -3.8 | -4,075.6% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 20.4 | 2,191.1% | |
Shares outstanding (eoy) | m | 16.60 | 43.18 | 38.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 3.5 | 178.4% | |
Avg P/E ratio | x | 33.5 | -9.4 | -356.6% | |
P/CF ratio (eoy) | x | 29.8 | -9.5 | -313.9% | |
Price / Book Value ratio | x | 10.3 | 1.8 | 583.8% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 1,561 | 4,917.5% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 151 | 1,361.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 446 | 2,756.4% | |
Other income | Rs m | 184 | 11 | 1,734.9% | |
Total revenues | Rs m | 12,480 | 457 | 2,732.7% | |
Gross profit | Rs m | 3,247 | -161 | -2,020.5% | |
Depreciation | Rs m | 281 | 2 | 14,050.0% | |
Interest | Rs m | 8 | 71 | 10.9% | |
Profit before tax | Rs m | 3,142 | -223 | -1,411.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | -56 | -1,505.2% | |
Profit after tax | Rs m | 2,295 | -166 | -1,379.1% | |
Gross profit margin | % | 26.4 | -36.0 | -73.3% | |
Effective tax rate | % | 27.0 | 25.3 | 106.7% | |
Net profit margin | % | 18.7 | -37.3 | -50.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 358 | 3,271.5% | |
Current liabilities | Rs m | 6,791 | 940 | 722.1% | |
Net working cap to sales | % | 40.0 | -130.6 | -30.7% | |
Current ratio | x | 1.7 | 0.4 | 453.0% | |
Inventory Days | Days | 263 | 85 | 307.5% | |
Debtors Days | Days | 343 | 1,135 | 30.3% | |
Net fixed assets | Rs m | 10,617 | 1,262 | 841.3% | |
Share capital | Rs m | 166 | 432 | 38.4% | |
"Free" reserves | Rs m | 7,265 | 450 | 1,613.1% | |
Net worth | Rs m | 7,431 | 882 | 842.3% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 1,620 | 1,378.4% | |
Interest coverage | x | 409.1 | -2.2 | -18,989.4% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 0.3 | 200.0% | |
Return on assets | % | 10.3 | -5.9 | -174.4% | |
Return on equity | % | 30.9 | -18.9 | -163.7% | |
Return on capital | % | 42.4 | -17.2 | -245.9% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 13.1 | 14.5 | 90.3% | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 1,605 | 65 | 2,488.2% | |
Fx inflow | Rs m | 1,465 | 0 | - | |
Fx outflow | Rs m | 1,605 | 65 | 2,488.2% | |
Net fx | Rs m | -140 | -65 | 217.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 109 | 2,166.7% | |
From Investments | Rs m | -215 | 5 | -4,653.7% | |
From Financial Activity | Rs m | -985 | -147 | 669.3% | |
Net Cashflow | Rs m | 1,160 | -34 | -3,456.4% |
Indian Promoters | % | 0.0 | 59.3 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 0.0 | - | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 40.8 | 118.2% | |
Shareholders | 56,778 | 35,313 | 160.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | BH.IMMUN&BIO | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | -2.69% | 0.45% |
1-Month | -1.15% | 6.17% | 2.55% |
1-Year | 0.73% | 31.70% | 56.14% |
3-Year CAGR | -8.76% | -9.09% | 15.22% |
5-Year CAGR | 4.97% | 32.05% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the BH.IMMUN&BIO share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of BH.IMMUN&BIO the stake stands at 59.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of BH.IMMUN&BIO.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
BH.IMMUN&BIO paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of BH.IMMUN&BIO.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.